Evidence map›Paper›PMID 35116907›Full record

ArticleTranslational cancer research2019

Dual drive coexistence of

You-Cai Zhu, Bing Wan, Li-Xin Wu, Xing-Liang Li, Wen-Xian Wang, Chun-Wei Xu, Wu Zhuang, Jian-Guo Wei, Kai-Qi Du

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

You-Cai Zhu *Department of Chest Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, Jiaxing 314000, China.
Bing Wan *Department of Respiratory and Critical Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing 210002, China.
Li-Xin WuDepartment of Chest Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, Jiaxing 314000, China.
Xing-Liang LiDepartment of Tumor Molecular Laboratory, Zhejiang Rongjun Hospital, Jiaxing 314000, China.
Wen-Xian WangDepartment of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou 310022, China.
Chun-Wei XuDepartment of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
Wu ZhuangDepartment of Medical Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China.
Jian-Guo WeiDepartment of Pathology, Shaoxing People's Hospital, Shaoxing 312000, China.
Kai-Qi DuDepartment of Chest Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, Jiaxing 314000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromosomal translocation resulting in the fusion between the echinoderm microtubule-associated protein-like 4 (

Indexed as

anaplastic lymphoma kinase (ALK) rearrangementKRAS mutationLung adenocarcinomanext-generation sequencing (NGS)

Identifiers

PMID35116907
PMCPMC8798733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.